Concepedia

Karel Eechoute

KE

11

Publications

822

Citations

11

H-Index

2009

Active since

Affiliations

Erasmus MC(Current)

Erasmus MC Cancer Institute

University Medical Center Groningen

The Netherlands Cancer Institute

Leiden University Medical Center

Karel Eechoute is an author at Erasmus MC specializing in medicine, cancer research, and tumor biology.

ORCID

Top concepts

Publications per year

2009–2020

11

Publications

11

Pharmacogenetic Pathway Analysis for Determination of Sunitinib-Induced Toxicity

Nielka P. van Erp, Karel Eechoute, A. A. van der Veldt et al. · Journal of Clinical Oncology · 2009 · 183 citations

Genetic Polymorphisms Associated with a Prolonged Progression-Free Survival in Patients with Metastatic Renal Cell Cancer Treated with Sunitinib

Astrid A.M. van der Veldt, Karel Eechoute, Hans Gelderblom et al. · Clinical Cancer Research · 2010 · 156 citations

A Long-term Prospective Population Pharmacokinetic Study on Imatinib Plasma Concentrations in GIST Patients

Karel Eechoute, Martin N. Fransson, An K. Reyners et al. · Clinical Cancer Research · 2012 · 109 citations · Full text

Sunitinib-Induced Hypothyroidism Is due to Induction of Type 3 Deiodinase Activity and Thyroidal Capillary Regression

Mariëtte H.W. Kappers, Joep H.M. van Esch, Frank Smedts et al. · The Journal of Clinical Endocrinology & Metabolism · 2011 · 102 citations

Polymorphisms in Endothelial Nitric Oxide Synthase (eNOS) and Vascular Endothelial Growth Factor (VEGF) Predict Sunitinib-Induced Hypertension

Karel Eechoute, Astrid A.M. van der Veldt, Sjoukje F. Oosting et al. · Clinical Pharmacology & Therapeutics · 2012 · 85 citations

, , +20

Rows per page

1–5 of 11